Online Share/Stock Trading & Investment Broker in India | mastertrust

Ipca Laboratories Ltd.

BSE : 124494 NSE : IPCALAB ISIN : INE571A01020 Industry : Pharmaceuticals & Drugs
1,907.05
Change: 3.95 (0.21 %)
As on 02-Mar-2021 03:44 PM
Prev.Close 1,903.10
Open 1,925.00
Day's High 1,929.00
Day's Low 1,851.50
Mkt.Cap ( Cr.) 24,191.31
Face Value 2
PE Ratio 22.67
PB Ratio 4.78

52 Week High Low

Low: 1,200.00
High: 2,460.00
LTP:1,907.05

Lifetime High Low

Low: 400.00
High: 2,460.00
LTP:1,907.05

Ipca Laboratories Ltd.

BSE : 124494 NSE : IPCALAB ISIN : INE571A01020 Industry : Pharmaceuticals & Drugs
1,907.50
B S Sip
Change: 4.65 (0.24 %)
As on 02-Mar-2021 03:50 PM
Prev.Close 1,902.85
Open 1,929.00
Day High 1,929.00
Day Low 1,851.25
Mkt.Cap ( Cr. ) 24,197.02
Face Value 2
P/E Ratio 22.67
PB Ratio 4.78

52 Week High Low

Low:1,162.00
High:2,455.55
LTP:1,907.50

Lifetime High Low

Low:400.00
High:1,029.00
LTP:1,907.50

P/E Ratio

52 W L(14.96)
52 W H(40.26)

P/E Ratio

52 W L(14.96)
52 W H(40.26)
Had I Invested a sum of 1,00,000 on the same day 5 years ago,the money would have become 336399.72 ( a of 27.46 p.a.)

Key Levels

Support Level 1 952.23
Support Level 2 936.52
Resistance Level 1 976.83
Resistance Level 2 985.72

Moving Average

20 Days 1,905.19
50 Days 2,032.50
100 Days 2,108.22
200 Days 1,957.23
No Data Available
FY 2020FY 2019FY 2018FY 2017FY 2016
EBDITA Margin (%)22.5020.6515.0514.4110.69
PBT Margin (%)17.9715.348.788.183.92
PAT Margin (%)14.9412.527.245.963.25
ROCE (%)20.8416.769.538.974.52
ROE (%)19.1815.609.027.914.10
FY 2020FY 2019FY 2018FY 2017FY 2016
Total Income ( Cr.)4,421.983,677.233,251.103,158.732,889.33
Gross Profit ( Cr.)963.66729.27457.16429.20272.68
Profit Before Tax ( Cr.)784.97557.39282.80258.20111.45
Tax ( Cr.)132.51102.4849.6969.9118.93
Profit After Tax ( Cr.)652.46454.91233.11188.2992.52
NAME DESIGNATION
Premchand Godha Chairman & Managing Director
Ajit Kumar Jain Joint Managing Director
Pranay Godha Executive Director
Prashant Godha Executive Director
Anand T Kusre Non Executive Independent Director
Dev Parkash Yadava Non Executive Independent Director
Manisha Premnath Non Executive Independent Director
Kamal Kishore Seth Non Executive Independent Director
Harish P Kamath Company Secretary
Ipca Laboratories reports Profit after tax of Rs 2599.70 Mln, in the December 2020 quarter
Type: CORPORATE RESULT
Date: 04-Feb-2021 12:57 PM
--
Ipca Laboratories reports Profit after tax of Rs 2756.80 Mln, in the September 2020 quarter
Type: CORPORATE RESULT
Date: 07-Nov-2020 11:53 AM
--
Ipca Laboratories in process of obtaining environmental clearance for new plant in MP
Type: NEWS
Date: 17-Aug-2020 11:39 AM
The company has already acquired land for the project
Healthcare Services industry stocks trade higher on the bourses
Type: MOVERS TODAY
Date: 23-Mar-2020 12:20 PM
Ipca Laboratories is currently trading at Rs 1407.95, up by 36.10 points or 2.63%
Ipca Laboratories reports Profit after tax of Rs 1966.30 Mln, in the December 2019 quarter
Type: CORPORATE RESULT
Date: 12-Feb-2020 01:21 PM
--
Ipca Laboratories enters into agreement with MMV
Type: NEWS
Date: 21-Dec-2019 10:01 AM
The company has entered into agreement to co-develop a novel antimalarial co-formulation named ‘Atoguanil’